Oxford BioMedica PLC | Income Statement
Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,375.00
13,618.00
15,909.00
27,776.00
37,590.00
66,778
Cost of Goods Sold (COGS) incl. D&A
1,536.00
4,812.00
7,466.00
15,510.00
22,817.00
27,120
Gross Income
3,839.00
8,806.00
8,443.00
12,266.00
14,773.00
39,658
SG&A Expense
16,776.00
20,416.00
25,388.00
26,581.00
23,254.00
34,095
EBIT
12,937.00
11,610.00
14,083.00
11,313.00
8,481.00
5,563
Unusual Expense
-
131.00
-
-
1,326.00
5,983
Non Operating Income/Expense
110.00
1,125.00
1,034.00
4,109.00
4,770.00
383
Interest Expense
-
235.00
1,891.00
4,919.00
9,414.00
6,220
Pretax Income
12,763.00
10,798.00
16,982.00
20,307.00
11,761.00
5,014
Income Tax
1,667.00
2,137.00
3,963.00
3,666.00
2,744.00
2,527
Consolidated Net Income
11,096.00
8,661.00
13,019.00
16,641.00
9,017.00
7,541
Net Income
11,096.00
8,661.00
13,019.00
16,641.00
9,017.00
7,541
Net Income After Extraordinaries
11,096.00
8,661.00
13,019.00
16,641.00
9,017.00
7,541
Net Income Available to Common
11,096.00
8,661.00
13,019.00
16,641.00
9,017.00
7,541
EPS (Basic)
0.39
0.21
0.25
0.30
0.14
0.12
Basic Shares Outstanding
28,323.00
40,385.80
51,404.00
55,563.70
61,913.30
65,188.40
EPS (Diluted)
0.39
0.21
0.25
0.30
0.15
0.11
Diluted Shares Outstanding
28,323.00
40,385.80
51,404.00
55,563.70
61,913.30
69,242.90
EBITDA
11,870.00
10,511.00
12,456.00
7,638.00
4,106.00
9,920
Other Operating Expense
-
-
2,862.00
3,002.00
-
-
Non-Operating Interest Income
64.00
53.00
26.00
34.00
38.00
71
About Oxford BioMedica
View Profile
